What is CaNCURE?

CaNCURE was created to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Over 50 trainees have already completed the program.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research lab.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
 Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.









Hear from our Alumni:

“Through my classroom education and experiences on co-op, I have learned about oncology and seen how debilitating both cancer and its treatment side-effects can be.  I am inspired by the possibilities of nanomedicine, and see potential uses in mitigating chemotherapy side effects.”

Jeremy Thong, Nursing, ’16

Trainee Spotlight

Vivian Zhang

Chemical Eng / Biochemistry, '21

Creating Animal Models of High-grade Serous Ovarian Cancer Cells

Daem Celestin

Cell and Molecular Biology, '21

The Nano-plasmonic Exosome (nPLEX) Assay for Pancreatic Ductal Adenocarcinoma Diagnosis and Prognosis

Adrienne Orriols

Behavioral Neuroscience, '19

Development and Characterization of Nano-Dinaciclib in Combination with Nano-Talazoparib for the Treatment of Breast Cancer

Upcoming Events

How to create a research e-portfolio

Wednesday, September 19, 2018

E-portfolios are a powerful tool for documenting and reflecting about experiential learning.  Come learn how to create an e-portfolio that talks about your CaNCURE experience.  We invite you to view the e-portfolios of our featured alumni, Rachel Fontana and Jordan Harris, or see the e-portfolios of other previous trainees from their individual profiles.      […]

435 Egan -- NEU, 3:25 PM

Mentor Spotlight

William Hahn, M.D., Ph.D.

Associate Professor of Medicine, HMS

We have a longstanding interest in cooperative genetic alterations that program malignant transformation and has developed many experimental model systems to study specific genetic alterations. Students will use therapeutic tumor-penetrating siRNA nanocomplexes to identify, validate, and understand potential therapeutic cancer.

Ross I Berbeco, Ph.D.

Associate Professor of Radiation Oncology, HMS

Our lab performs theoretical and experimental studies of systemically administered nanoparticles and their role in enhancing radiation therapy for cancer treatment. Students will have the opportunity to functionalize these particles with tumor-specific targeting moieties and study how this leads to localized disruption of the tumor vasculature.

Trainee Spotlight

Rreze Grajcevci

Mostafa Abdelhalim

Biochemistry, '21

Targeted Delivery of Liposomes using PARP Inhibitors to Treat Non-Small Cell Lung Cancer

Vivian Zhang

Chemical Eng / Biochemistry, '21

Creating Animal Models of High-grade Serous Ovarian Cancer Cells

 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...